SEC Form 4 · accession 0001437749-17-009602
DEXTERA SURGICAL INC · DXTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael A. Bates
Director
Period of report
May 16, 2017
Accepted (ET)
May 18, 2017 · 9:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178104
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Convertible Preferred StockF1,F2,F3 | $0.27 | May 16, 2017 | P | 50 | A | — | — | Common Stock | 185,200 | 50 | D |
| Series 1 Convertible Preferred StockF7,F4,F5 | $0.27 | May 16, 2017 | P | 185,200 | A | — | — | Common Stock | 185,200 | 185,200 | D |
| Series 2 Convertible Preferred StockF7,F4,F6 | $0.27 | May 16, 2017 | P | 92,600 | A | — | — | Common Stock | 92,600 | 92,600 | D |
Explanation of responses
- F1Each share of Series B convertible preferred stock was sold with warrants to purchase up to 3,704 shares of common stock (referred to as "Series 1 warrants") and warrants to purchase up to 1,852 shares of common stock (referred to as "Series 2 warrants").
- F2Subject to certain ownership limitations, each share of the Series B convertible preferred stock is convertible at any time at the option of the holder into 3,704 shares of common stock.
- F3There is no expiration date.
- F4Subject to certain ownership limitations, the warrants are immediately exercisable.
- F5The warrant expires on the fifth anniversary of the date of issuance.
- F6The warrant expires on the first anniversary of the date of issuance.
- F7The reported securities are included in the price equal to $1,000 per share of the Series B convertible preferred stock purchased.